TAC-话题@MedSci

#TAC#

115篇内容 | 2663人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2201784, encodeId=9e692201e84dd, content=<a href='/topic/show?id=74a140404de' target=_blank style='color:#2F92EE;'>#囊肿#</a> <a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a> <a href='/topic/show?id=42991141208e' target=_blank style='color:#2F92EE;'>#非肿瘤性肿瘤相关囊肿#</a>, objectTitle=什么是“非肿瘤性肿瘤相关囊肿”, objectType=article, longId=824332, objectId=59a08243326a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221121/1669073122328_4754896.jpeg, objectUrl=/article/show_article.do?id=59a08243326a, replyNumber=0, likeNumber=90, createdTime=2024-05-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=59a08243326a, moduleTitle=什么是“非肿瘤性肿瘤相关囊肿”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59a08243326a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2033775, encodeId=b8472033e7508, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=“神药”再发威！助力肝癌TACE后缓解，还能降低局部复发风险达72%！, objectType=article, longId=737564, objectId=6b6de3756448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b6de3756448, replyNumber=0, likeNumber=93, createdTime=2023-03-06, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b6de3756448, moduleTitle=“神药”再发威！助力肝癌TACE后缓解，还能降低局部复发风险达72%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b6de3756448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033772, encodeId=d7d62033e72ba, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=European Radiology：预测生存期的最佳反应时间点与肝细胞癌TACE术后的肿瘤负荷有关, objectType=article, longId=736018, objectId=8b06e36018f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b06e36018f7, replyNumber=0, likeNumber=108, createdTime=2023-03-18, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b06e36018f7, moduleTitle=European Radiology：预测生存期的最佳反应时间点与肝细胞癌TACE术后的肿瘤负荷有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b06e36018f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033776, encodeId=b2652033e76ea, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Investigative Radiology：基于锥形束CT扫描的TACE术后药物剂量的空间预测, objectType=article, longId=737604, objectId=c3c5e3760468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3c5e3760468, replyNumber=0, likeNumber=81, createdTime=2022-10-02, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3c5e3760468, moduleTitle=Investigative Radiology：基于锥形束CT扫描的TACE术后药物剂量的空间预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3c5e3760468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033773, encodeId=4d532033e7334, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=STTT：PROTAC的80多个热门靶点及248个代表性分子, objectType=article, longId=736909, objectId=9425e369092e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9425e369092e, replyNumber=0, likeNumber=98, createdTime=2022-11-03, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9425e369092e, moduleTitle=STTT：PROTAC的80多个热门靶点及248个代表性分子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9425e369092e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033765, encodeId=2a6c2033e65ea, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=2022年3月14日简报：上海昨日新增本土新冠肺炎确诊病例41+128例；张文宏认为这波疫情是倒春寒；全球疫情反弹，德尔塔克戎（deltacron）变体引发关注, objectType=article, longId=300721, objectId=27fd300e2129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27fd300e2129, replyNumber=0, likeNumber=77, createdTime=2022-08-09, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27fd300e2129, moduleTitle=2022年3月14日简报：上海昨日新增本土新冠肺炎确诊病例41+128例；张文宏认为这波疫情是倒春寒；全球疫情反弹，德尔塔克戎（deltacron）变体引发关注, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27fd300e2129)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033762, encodeId=50852033e6271, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Liver Cancer：TACTICS研究表明在TACE基础性加用索拉非尼可改善不可切除肝细胞癌（HCC）患者的PFS，但不能改善患者的OS, objectType=article, longId=299277, objectId=87e42992e798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87e42992e798, replyNumber=0, likeNumber=96, createdTime=2022-03-05, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87e42992e798, moduleTitle=Liver Cancer：TACTICS研究表明在TACE基础性加用索拉非尼可改善不可切除肝细胞癌（HCC）患者的PFS，但不能改善患者的OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87e42992e798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033774, encodeId=168c2033e741b, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=AJH：地西他滨和伏立诺他联合 FLAG 化疗治疗儿科复发/难治性 AML：儿童白血病和淋巴瘤 (TACL) 联盟的治疗进展报告, objectType=article, longId=300245, objectId=d19a300245bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d19a300245bc, replyNumber=0, likeNumber=113, createdTime=2022-07-02, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d19a300245bc, moduleTitle=AJH：地西他滨和伏立诺他联合 FLAG 化疗治疗儿科复发/难治性 AML：儿童白血病和淋巴瘤 (TACL) 联盟的治疗进展报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d19a300245bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033771, encodeId=3f9d2033e71d3, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=European Radiology：基于AI的全自动脾分割在肝癌TACE患者风险分层中的应用, objectType=article, longId=735918, objectId=d69de35918fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d69de35918fd, replyNumber=0, likeNumber=79, createdTime=2023-02-02, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d69de35918fd, moduleTitle=European Radiology：基于AI的全自动脾分割在肝癌TACE患者风险分层中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d69de35918fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033757, encodeId=1e372033e5704, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效, objectType=article, longId=294112, objectId=1b49294112ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b49294112ae, replyNumber=0, likeNumber=90, createdTime=2022-07-08, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b49294112ae, moduleTitle=Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b49294112ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033754, encodeId=e2152033e54de, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性, objectType=article, longId=292954, objectId=a2d3292954c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d3292954c0, replyNumber=0, likeNumber=87, createdTime=2022-04-04, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d3292954c0, moduleTitle=Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d3292954c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033763, encodeId=113f2033e638e, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Contact Dermatitis：手部湿疹和生活方式因素：吸烟、慢性压力和肥胖的关系研究, objectType=article, longId=299359, objectId=fcaf2993595b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcaf2993595b, replyNumber=0, likeNumber=91, createdTime=2022-11-04, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcaf2993595b, moduleTitle=Contact Dermatitis：手部湿疹和生活方式因素：吸烟、慢性压力和肥胖的关系研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcaf2993595b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033756, encodeId=161c2033e56fe, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Neurology：ATACH-2与 MISTIE Ⅲ临床试验汇总分析——伴潜在脑小血管病变的原发性脑出血患者出血量更小，血肿扩张几率更低，或预后更佳, objectType=article, longId=294020, objectId=e4e7294020e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4e7294020e5, replyNumber=0, likeNumber=96, createdTime=2022-07-29, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4e7294020e5, moduleTitle=Neurology：ATACH-2与 MISTIE Ⅲ临床试验汇总分析——伴潜在脑小血管病变的原发性脑出血患者出血量更小，血肿扩张几率更低，或预后更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4e7294020e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033766, encodeId=4b3c2033e66bf, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=WHO证实新冠新变体Deltacron存在，由Delta和Omicron重组而来, objectType=article, longId=300783, objectId=69ea300e83ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69ea300e83ca, replyNumber=0, likeNumber=79, createdTime=2022-06-20, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69ea300e83ca, moduleTitle=WHO证实新冠新变体Deltacron存在，由Delta和Omicron重组而来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69ea300e83ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033768, encodeId=86e72033e684a, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后, objectType=article, longId=728872, objectId=66cae28872f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66cae28872f3, replyNumber=0, likeNumber=82, createdTime=2022-12-04, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66cae28872f3, moduleTitle=J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66cae28872f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033752, encodeId=e7842033e52db, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标, objectType=article, longId=221712, objectId=37eb221e1225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37eb221e1225, replyNumber=0, likeNumber=97, createdTime=2022-09-28, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37eb221e1225, moduleTitle=Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37eb221e1225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033758, encodeId=08b02033e5823, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Nat Rev Drug Discov：PROTAC过去20年的发展历程, objectType=article, longId=294851, objectId=a3a829485153, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3a829485153, replyNumber=0, likeNumber=74, createdTime=2022-05-23, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3a829485153, moduleTitle=Nat Rev Drug Discov：PROTAC过去20年的发展历程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3a829485153)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033759, encodeId=cefe2033e5963, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后, objectType=article, longId=295066, objectId=890729506606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=890729506606, replyNumber=0, likeNumber=79, createdTime=2022-11-07, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=890729506606, moduleTitle=Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=890729506606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033767, encodeId=665e2033e67aa, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Contact Dermatitis：手卫生产品选什么？肥皂，酒精还是湿巾？, objectType=article, longId=726079, objectId=771de2607949, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=771de2607949, replyNumber=0, likeNumber=73, createdTime=2022-10-17, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=771de2607949, moduleTitle=Contact Dermatitis：手卫生产品选什么？肥皂，酒精还是湿巾？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=771de2607949)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2033769, encodeId=8ee72033e69b3, content=<a href='/topic/show?id=fc431e0708f' target=_blank style='color:#2F92EE;'>#TAC#</a>, objectTitle=Nature Biotechnology：调控蛋白质稳态，司龙龙团队建立PROTAC减毒疫苗新策略, objectType=article, longId=731364, objectId=6c56e31364d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c56e31364d4, replyNumber=0, likeNumber=94, createdTime=2022-12-21, rootId=0, userName=grace5700, userId=b05b180, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c56e31364d4, moduleTitle=Nature Biotechnology：调控蛋白质稳态，司龙龙团队建立PROTAC减毒疫苗新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c56e31364d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TAC

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#囊肿# #TAC# #非肿瘤性肿瘤相关囊肿#

什么是“非肿瘤性肿瘤相关囊肿”

2024-05-04发表于上海

grace5700 (审核中...)

前往app查看评论内容

#TAC#

“神药”再发威！助力肝癌TACE后缓解，还能降低局部复发风险达72%！

2023-03-06

grace5700 (审核中...)

前往app查看评论内容

#TAC#

European Radiology：预测生存期的最佳反应时间点与肝细胞癌TACE术后的肿瘤负荷有关

2023-03-18

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Investigative Radiology：基于锥形束CT扫描的TACE术后药物剂量的空间预测

2022-10-02

grace5700 (审核中...)

前往app查看评论内容

#TAC#

STTT：PROTAC的80多个热门靶点及248个代表性分子

2022-11-03

柳叶一刀 (审核中...)

前往app查看评论内容

#TAC#

2022年3月14日简报：上海昨日新增本土新冠肺炎确诊病例41+128例；张文宏认为这波疫情是倒春寒；全球疫情反弹，德尔塔克戎（deltacron）变体引发关注

2022-08-09

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Liver Cancer：TACTICS研究表明在TACE基础性加用索拉非尼可改善不可切除肝细胞癌（HCC）患者的PFS，但不能改善患者的OS

2022-03-05

grace5700 (审核中...)

前往app查看评论内容

#TAC#

AJH：地西他滨和伏立诺他联合 FLAG 化疗治疗儿科复发/难治性 AML：儿童白血病和淋巴瘤 (TACL) 联盟的治疗进展报告

2022-07-02

grace5700 (审核中...)

前往app查看评论内容

#TAC#

European Radiology：基于AI的全自动脾分割在肝癌TACE患者风险分层中的应用

2023-02-02

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效

2022-07-08

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性

2022-04-04

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Contact Dermatitis：手部湿疹和生活方式因素：吸烟、慢性压力和肥胖的关系研究

2022-11-04

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Neurology：ATACH-2与 MISTIE Ⅲ临床试验汇总分析——伴潜在脑小血管病变的原发性脑出血患者出血量更小，血肿扩张几率更低，或预后更佳

2022-07-29

grace5700 (审核中...)

前往app查看评论内容

#TAC#

WHO证实新冠新变体Deltacron存在，由Delta和Omicron重组而来

2022-06-20

grace5700 (审核中...)

前往app查看评论内容

#TAC#

J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后

2022-12-04

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标

2022-09-28

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Nat Rev Drug Discov：PROTAC过去20年的发展历程

2022-05-23

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后

2022-11-07

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Contact Dermatitis：手卫生产品选什么？肥皂，酒精还是湿巾？

2022-10-17

grace5700 (审核中...)

前往app查看评论内容

#TAC#

Nature Biotechnology：调控蛋白质稳态，司龙龙团队建立PROTAC减毒疫苗新策略

2022-12-21

科室
- - 订阅+
  - 更多科室
工具
服务